IQE (IQE) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
30 Jun, 2026Executive summary
Revenue grew 27% year-over-year to £66 million in H1 2024, driven by strong wireless segment performance and ongoing market recovery, though growth was more moderate than forecast due to regional and segment variability.
Adjusted EBITDA improved to £6.6 million, swinging from a £5.7 million loss in H1 2023, reflecting improved manufacturing utilization, cost optimization, and operational efficiencies.
Strategic focus remains on diversification into high-value markets such as GaN power and microLED displays, with ongoing investment in R&D and production capacity.
Proposed IPO of the Taiwan subsidiary aims to accelerate growth initiatives and provide additional cash resources, with listing targeted for H1 2025.
Financial highlights
H1 2024 revenue reached £66 million, up £14 million or 27% year-over-year, and up 53% on a constant currency basis.
Adjusted EBITDA improved by £12.3 million year-over-year, reaching £6.6 million.
Adjusted EBIT loss narrowed to £7.2 million, a £10.2 million improvement from H1 2023.
Adjusted net debt increased to £17.0 million as of June 30, 2024, with £7.8 million in cash equivalents.
Reported diluted EPS was (1.57p), improved from (2.57p) in H1 2023.
Outlook and guidance
Year-on-year growth in revenue and Adjusted EBITDA is expected for the full year, but both are anticipated to be at the lower end of earlier forecasts (£130.0m–£153.7m revenue, £11.1m–£16.6m EBITDA) due to the pace of industry recovery.
The company remains confident in continued industry recovery but expects ongoing variability in H2 2024, with full recovery anticipated in 2025.
Commitment to diversification and growth strategy, with focus on technology roadmap and customer partnerships.
Taiwan IPO on track for H1 2025.
Latest events from IQE
- FY 2026 revenue growth forecast raised to over 30% on strong H1 demand and robust cash position.IQE
H1 2026 TU21 Jul 2026 - Adjusted EBITDA nearly doubled on flat revenue; strategic review targets debt-free growth.IQE
H2 20248 Jul 2026 - £81m fundraising, photonics growth, and strong H2 recovery set up >20% revenue growth for 2026.IQE
H2 202528 May 2026 - Board changes, GenAI-driven strategy, and technology innovation highlighted amid industry recovery.IQE
AGM 20243 Feb 2026 - Revenue and order book strength position the group for growth as strategic review advances.IQE
Trading Update12 Jan 2026 - Revenue fell 31% year-over-year to £45.3m, with deepening losses and a potential full sale.IQE
H1 202520 Oct 2025 - IQE launches a strategic review and seeks £15m financing as 2024 revenue remains flat.IQE
Trading Update13 Jun 2025 - H1 2024 revenue up at least 25% year-on-year, with trading meeting expectations.IQE
Trading Update13 Jun 2025 - FY24 revenue and EBITDA to surpass expectations; strategic review and financing progressing.IQE
Trading Update6 Jun 2025